{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T12:43:20Z","timestamp":1776861800711,"version":"3.51.2"},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["1R21CA78626-01"],"award-info":[{"award-number":["1R21CA78626-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Jan Calloway"},{"name":"Wayne Calloway"}],"content-domain":{"domain":["brachyjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.brachy.2016.02.003","type":"journal-article","created":{"date-parts":[[2016,4,30]],"date-time":"2016-04-30T09:32:21Z","timestamp":1462008741000},"page":"266-273","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Long-term outcome of magnetic resonance spectroscopic image\u2013directed dose escalation for prostate brachytherapy"],"prefix":"10.1016","volume":"15","author":[{"given":"Martin T.","family":"King","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola J.","family":"Nasser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nitin","family":"Mathur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gil'ad N.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marisa A.","family":"Kollmeier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jasper","family":"Yuen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hebert A.","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Pei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiya","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristen L.","family":"Zakian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Zaider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Zelefsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brachy.2016.02.003_bib1","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ijrobp.2007.06.054","article-title":"Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer","volume":"70","author":"Kuban","year":"2008","journal-title":"Int\u00a0J\u00a0Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2016.02.003_bib2","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1200\/JCO.2009.25.8475","article-title":"Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from proton radiation oncology group\/American College of Radiology 95-09","volume":"28","author":"Zietman","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.brachy.2016.02.003_bib3","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.ijrobp.2007.11.066","article-title":"Long-term results of conformal radiotherapy for prostate cancer: impact of dose escalation on biochemical tumor control and distant metastases-free survival outcomes","volume":"71","author":"Zelefsky","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2016.02.003_bib4","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0360-3016(98)00006-6","article-title":"A dose-response study for I-125 prostate implants","volume":"41","author":"Stock","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2016.02.003_bib5","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.brachy.2011.08.003","article-title":"Predicting biochemical tumor control after brachytherapy for clinically localized prostate cancer: the Memorial Sloan-Kettering Cancer Center experience","volume":"11","author":"Zelefsky","year":"2012","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2016.02.003_bib6","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.ijrobp.2014.08.340","article-title":"A dose-response analysis of biochemical control outcomes after (125)I monotherapy for patients with favorable-risk prostate cancer","volume":"90","author":"Shiraishi","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2016.02.003_bib7","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/j.juro.2007.11.063","article-title":"Influence of local tumor control on distant metastases and cancer related mortality after external beam radiotherapy for prostate cancer","volume":"179","author":"Zelefsky","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.brachy.2016.02.003_bib8","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.juro.2010.09.099","article-title":"Influence of pretreatment and treatment factors on intermediate to long-term outcome after prostate brachytherapy","volume":"185","author":"Stone","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.brachy.2016.02.003_bib9","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0360-3016(02)02795-5","article-title":"Analysis of intraprostatic failures in patients treated with hormonal therapy and radiotherapy: implications for conformal therapy planning","volume":"53","author":"Cellini","year":"2002","journal-title":"Int\u00a0J\u00a0Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2016.02.003_bib10","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ijrobp.2007.03.065","article-title":"Clinically significant prostate cancer local recurrence after radiation therapy occurs at the site of primary tumor: magnetic resonance imaging and step-section pathology evidence","volume":"69","author":"Pucar","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2016.02.003_bib11","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0360-3016(00)00655-6","article-title":"Postimplantation dosimetric analysis of permanent transperineal prostate implantation: improved dose distributions with an intraoperative computer-optimized conformal planning technique","volume":"48","author":"Zelefsky","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2016.02.003_bib12","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0360-3016(02)04142-1","article-title":"Improved conformality and decreased toxicity with intraoperative computer-optimized transperineal ultrasound-guided prostate brachytherapy","volume":"55","author":"Zelefsky","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2016.02.003_bib13","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1148\/radiology.198.3.8628874","article-title":"Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with\u00a0high (0.24-0.7-cm3) spatial resolution","volume":"198","author":"Kurhanewicz","year":"1996","journal-title":"Radiology"},{"key":"10.1016\/j.brachy.2016.02.003_bib14","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1148\/radiology.213.2.r99nv23473","article-title":"Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging\u2013clinicopathologic study","volume":"213","author":"Scheidler","year":"1999","journal-title":"Radiology"},{"key":"10.1016\/j.brachy.2016.02.003_bib15","first-page":"249","article-title":"Intraoperative conformal optimization for transperineal prostate implantation using magnetic resonance spectroscopic imaging","volume":"6","author":"Zelefsky","year":"2000","journal-title":"Cancer J"},{"key":"10.1016\/j.brachy.2016.02.003_bib16","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0360-3016(00)00557-5","article-title":"Treatment planning for prostate implants using magnetic-resonance spectroscopy imaging","volume":"47","author":"Zaider","year":"2000","journal-title":"Int\u00a0J\u00a0Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2016.02.003_bib17","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/S0360-3016(02)03805-1","article-title":"Towards integrating functional imaging in the treatment of prostate cancer with radiation: the registration of the MR spectroscopy imaging to ultrasound\/CT images and its implementation in treatment planning","volume":"54","author":"Mizowaki","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2016.02.003_bib18","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ijrobp.2006.08.030","article-title":"Five-year outcome of intraoperative conformal permanent I-125 interstitial implantation for patients with clinically localized prostate cancer","volume":"67","author":"Zelefsky","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2016.02.003_bib19","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.ijrobp.2014.06.031","article-title":"Dose to the bladder neck is the most important predictor for acute and late toxicity after low-dose-rate prostate brachytherapy: implications for establishing new dose constraints for treatment planning","volume":"90","author":"Hathout","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2016.02.003_bib20","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0360-3016(01)02609-8","article-title":"Magnetic resonance spectroscopic imaging-guided brachytherapy for localized prostate cancer","volume":"52","author":"DiBiase","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2016.02.003_bib21","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.ijrobp.2004.02.055","article-title":"Inverse planning for HDR prostate brachytherapy used to boost dominant intraprostatic lesions defined by magnetic resonance spectroscopy imaging","volume":"59","author":"Pouliot","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2016.02.003_bib22","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.radonc.2007.11.024","article-title":"Class solution in inverse planned HDR prostate brachytherapy for dose escalation of DIL defined by combined MRI\/MRSI","volume":"88","author":"Kim","year":"2008","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2016.02.003_bib23","doi-asserted-by":"crossref","first-page":"26","DOI":"10.5114\/jcb.2011.21040","article-title":"Interactive, multi-modality image registrations for combined MRI\/MRSI-planned HDR prostate brachytherapy","volume":"1","author":"Reed","year":"2011","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.brachy.2016.02.003_bib24","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1186\/1471-2407-10-472","article-title":"MRS-guided HDR brachytherapy boost to the dominant intraprostatic lesion in high risk localised prostate cancer","volume":"10","author":"Kazi","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.brachy.2016.02.003_bib25","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0360-3016(00)00646-5","article-title":"Feasibility and acute toxicities of radioimmunoguided prostate brachytherapy","volume":"48","author":"Ellis","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2016.02.003_bib26","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S0360-3016(03)00588-1","article-title":"Four-year biochemical outcome after radioimmunoguided transperineal brachytherapy for patients with prostate adenocarcinoma","volume":"57","author":"Ellis","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2016.02.003_bib27","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.brachy.2007.01.006","article-title":"Rectal morbidity after permanent prostate brachytherapy with dose escalation to biologic target volumes identified by SPECT\/CT fusion","volume":"6","author":"Ellis","year":"2007","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2016.02.003_bib28","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ijrobp.2009.04.049","article-title":"Dose escalation to the dominant intraprostatic lesion defined by sextant biopsy in a permanent prostate I-125 implant: a prospective comparative toxicity analysis","volume":"77","author":"Gaudet","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2016.02.003_bib29","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.brachy.2014.05.006","article-title":"Ultrasound-planned high-dose-rate prostate brachytherapy: dose painting to the dominant intraprostatic lesion","volume":"13","author":"Crook","year":"2014","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2016.02.003_bib30","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.brachy.2013.10.011","article-title":"Multi-parametric MRI-guided focal tumor boost using HDR prostate brachytherapy: a feasibility study","volume":"13","author":"Mason","year":"2014","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2016.02.003_bib31","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3109\/0284186X.2010.530688","article-title":"Feasibility of safe ultra-high (EQD(2)>100 Gy) dose escalation on dominant intra-prostatic lesions (DILs) by Helical Tomotheraphy","volume":"50","author":"Maggio","year":"2011","journal-title":"Acta Oncol"},{"key":"10.1016\/j.brachy.2016.02.003_bib32","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/COC.0b013e318209cd8f","article-title":"Intensity-modulated radiotherapy with simultaneous integrated boost to dominant intraprostatic lesion: preliminary report on toxicity","volume":"35","author":"Ippolito","year":"2012","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.brachy.2016.02.003_bib33","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ijrobp.2005.12.046","article-title":"IMRT boost dose planning on dominant intraprostatic lesions: gold marker-based three-dimensional fusion of CT with dynamic contrast-enhanced and 1H-spectroscopic MRI","volume":"65","author":"van Lin","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2016.02.003_bib34","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.urology.2010.01.067","article-title":"Real-time intraoperative computed tomography assessment of quality of permanent interstitial seed implantation for prostate cancer","volume":"76","author":"Zelefsky","year":"2010","journal-title":"Urology"},{"key":"10.1016\/j.brachy.2016.02.003_bib35","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ijrobp.2008.07.055","article-title":"Regarding the focal treatment of prostate cancer: inference of the Gleason grade from magnetic resonance spectroscopic imaging","volume":"74","author":"Brame","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472116000180?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472116000180?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:10:04Z","timestamp":1761531004000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472116000180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S1538472116000180"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2016.02.003","relation":{},"ISSN":["1538-4721"],"issn-type":[{"value":"1538-4721","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term outcome of magnetic resonance spectroscopic image\u2013directed dose escalation for prostate brachytherapy","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2016.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}